{"id":"https://openalex.org/W1040767786","doi":null,"title":"Od dysforii do depresji. rola dynorfin i receptor\u00f3w opioidowych kappa w patofizjologii chor\u00f3b zwi\u0105zanych ze stresem","display_name":"Od dysforii do depresji. rola dynorfin i receptor\u00f3w opioidowych kappa w patofizjologii chor\u00f3b zwi\u0105zanych ze stresem","alternate_titles":[],"publication_year":2013,"publication_date":"2013-01-01","ids":{"openalex":"https://openalex.org/W1040767786","mag":"1040767786"},"language":"pl","primary_location":{"id":"mag:1040767786","doi":null,"is_oa":false,"landing_page_url":"https://kosmos.ptpk.org/index.php/Kosmos/article/view/1115","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Kosmos","raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W1040767786"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034332564","display_name":"Przemys\u0142aw Eligiusz Cie\u015blak","orcid":"https://orcid.org/0000-0002-0543-8445","observed_orcids":["https://orcid.org/0000-0002-0543-8445"]},"institutions":[{"id":"https://openalex.org/I4210120768","display_name":"Maj Institute of Pharmacology","ror":"https://ror.org/0288swk05","country_code":"PL","type":"facility","lineage":["https://openalex.org/I4210120768","https://openalex.org/I99542240"]},{"id":"https://openalex.org/I99542240","display_name":"Polish Academy of Sciences","ror":"https://ror.org/01dr6c206","country_code":"PL","type":"government","lineage":["https://openalex.org/I99542240"]}],"countries":["PL"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Przemys\u0142aw Eligiusz Cie\u015blak","raw_affiliation_strings":["Instytut Farmakologii PAN, Sm\u0119tna 12, 31-343, Krak\u00f3w, Polska"],"raw_orcid":"https://orcid.org/0000-0002-0543-8445","affiliations":[{"raw_affiliation_string":"Instytut Farmakologii PAN, Sm\u0119tna 12, 31-343, Krak\u00f3w, Polska","institution_ids":["https://openalex.org/I4210120768","https://openalex.org/I99542240"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5034332564"],"corresponding_institution_ids":["https://openalex.org/I4210120768","https://openalex.org/I99542240"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"62","issue":"4","first_page":"485","last_page":"490"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10529","display_name":"Stress Responses and Cortisol","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2802","display_name":"Behavioral Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dynorphin","display_name":"dynorphin","score":0.9599999785423279},{"id":"https://openalex.org/keywords/kappa-opioid-receptor","display_name":"kappa opioid receptor","score":0.9950000047683716},{"id":"https://openalex.org/keywords/stress","display_name":"stress","score":0.5920000076293945},{"id":"https://openalex.org/keywords/depression","display_name":"depression","score":0.7630000114440918},{"id":"https://openalex.org/keywords/dysphoria","display_name":"dysphoria","score":0.8259999752044678},{"id":"https://openalex.org/keywords/chronic-stress","display_name":"chronic stress","score":0.9240000247955322},{"id":"https://openalex.org/keywords/stress-sensitization","display_name":"stress sensitization","score":0.9089999794960022},{"id":"https://openalex.org/keywords/stress-related-disorders","display_name":"stress-related disorders","score":0.7620000243186951},{"id":"https://openalex.org/keywords/kappa-opioid-receptor-antagonist","display_name":"kappa opioid receptor antagonists","score":0.8240000009536743},{"id":"https://openalex.org/keywords/anxiety-disorders","display_name":"anxiety disorders","score":0.7009999752044678},{"id":"https://openalex.org/keywords/addiction","display_name":"addiction","score":0.9380000233650208},{"id":"https://openalex.org/keywords/pain-relief","display_name":"analgesia","score":0.746999979019165},{"id":"https://openalex.org/keywords/aversion","display_name":"aversion","score":0.5379999876022339},{"id":"https://openalex.org/keywords/homeostasis","display_name":"homeostasis","score":0.8830000162124634}],"concepts":[{"id":"https://openalex.org/C151077648","wikidata":"https://www.wikidata.org/wiki/Q324076","display_name":"Dynorphin","level":5,"score":0.8966141939163208},{"id":"https://openalex.org/C184389661","wikidata":"https://www.wikidata.org/wiki/Q14897645","display_name":"\u03ba-opioid receptor","level":4,"score":0.7790735960006714},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.5351316332817078},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.47988975048065186},{"id":"https://openalex.org/C48856860","wikidata":"https://www.wikidata.org/wiki/Q12029","display_name":"Addiction","level":2,"score":0.44013577699661255},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.43105998635292053},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4185374677181244},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.354448139667511},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.34561866521835327},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3430193066596985},{"id":"https://openalex.org/C88016717","wikidata":"https://www.wikidata.org/wiki/Q417189","display_name":"Opioid peptide","level":4,"score":0.32640624046325684},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.23988765478134155}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:1040767786","doi":null,"is_oa":false,"landing_page_url":"https://kosmos.ptpk.org/index.php/Kosmos/article/view/1115","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Kosmos","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":37,"referenced_works":["https://openalex.org/W1964384291","https://openalex.org/W1971030284","https://openalex.org/W1975064257","https://openalex.org/W1979031324","https://openalex.org/W1980915383","https://openalex.org/W1981183620","https://openalex.org/W1983494600","https://openalex.org/W1996987808","https://openalex.org/W2008836462","https://openalex.org/W2009208338","https://openalex.org/W2010158373","https://openalex.org/W2010531200","https://openalex.org/W2012618677","https://openalex.org/W2020897240","https://openalex.org/W2028980996","https://openalex.org/W2029507624","https://openalex.org/W2029584624","https://openalex.org/W2032643119","https://openalex.org/W2037457092","https://openalex.org/W2042911859","https://openalex.org/W2047762719","https://openalex.org/W2048763187","https://openalex.org/W2062106032","https://openalex.org/W2071979087","https://openalex.org/W2079086643","https://openalex.org/W2080242611","https://openalex.org/W2084003388","https://openalex.org/W2091939203","https://openalex.org/W2110432917","https://openalex.org/W2116629441","https://openalex.org/W2144312659","https://openalex.org/W2154543554","https://openalex.org/W2166133075","https://openalex.org/W2167295928","https://openalex.org/W2170190816","https://openalex.org/W2253937444","https://openalex.org/W4322696862"],"related_works":["https://openalex.org/W2062106032","https://openalex.org/W2193936724","https://openalex.org/W499864","https://openalex.org/W1552844612","https://openalex.org/W2029584624","https://openalex.org/W1979031324","https://openalex.org/W4322696862","https://openalex.org/W1964384291","https://openalex.org/W2522876156","https://openalex.org/W1559636823"],"abstract_inverted_index":{"Stress":[0],"is":[1],"a":[2],"complex":[3],"phenomenon":[4],"which":[5,21],"influences":[6],"organism's":[7,23],"health":[8],"and":[9,12,42,51,61,87],"functioning.":[10],"Dynorphins":[11],"kappa":[13,53,74],"opioid":[14,39,54,75],"receptors":[15],"are":[16],"part":[17],"of":[18,35,66,83],"endogenous":[19],"system":[20],"controls":[22],"homeostasis.":[24],"Stressors":[25],"induce":[26,58],"dynorphins":[27],"secretion":[28],"in":[29,33,64],"brain":[30],"structures":[31],"involved":[32],"control":[34],"stress":[36,50,59,67],"reaction.":[37],"Kappa":[38],"receptor-mediated":[40],"analgesia":[41],"aversion":[43],"motivates":[44],"to":[45],"escape":[46],"threat.":[47],"However,":[48],"chronic":[49],"prolonged":[52],"receptor":[55,76],"activation":[56],"can":[57],"sensitization,":[60],"cause":[62],"increase":[63],"risk":[65],"related":[68],"disorders.":[69],"Preclinical":[70],"data":[71],"suggests":[72],"that":[73],"by":[77],"antagonists":[78],"have":[79],"potential":[80],"for":[81],"treatment":[82],"depression,":[84],"anxiety":[85],"disorders":[86],"addiction.":[88]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1040767786","counts_by_year":[],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2016-06-24T00:00:00"}
